Delivery Order SPE2DR25D3012-SPE2DR26F4E9G
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $1,941.36 delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 mg Inhalation Capsules (60-count) on August 25, 2025, with completion scheduled for September 16, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The award was competitively...
- The Defense Logistics Agency has awarded a delivery order valued at $1,294.24 to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60-count), with an ultimate completion date of November 26, 2025. This non-set-aside competitive award was issued on November 4, 2025, under firm fixed pricing terms. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,132.50 to AmerisourceBergen Drug Corp for INBRIJA 42 mg inhalation capsules (60-count) on December 18, 2025, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,876.50 firm-fixed-price delivery order is for the supply of INBRIJA 42 MG INHALATION CAPSULES. This contract has an ultimate completion date of August 8, 2024 and is not set aside for any specific business category. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This delivery order, valued at $3,882.72, awards AmerisourceBergen Drug Corp the supply of INBRIJA 42 MG inhalation capsules (60-count units) under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain. The award was made on September 16, 2025, without a set-aside designation, indicating the contract was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Inbrija 42 mg inhalation capsules (60-count package) under a firm fixed-price contract with a ceiling value of $1,879.50. This competitive award, with no set-aside designation, utilizes the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026....
- The Defense Logistics Agency awarded a $1,941.36 delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60-count package) on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price, competitively awarded contract (non-set-aside) will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60 count) valued at $1,941.36 under a firm fixed price contract type. This award, issued on July 24, 2025, represents a non-competitive, non-set-aside transaction with an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,941.36 for INBRIJA 42 mg inhalation capsules (60-count) by the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense. The contract, awarded on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a firm fixed-price, competitively awarded procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of INBRIJA 42 mg inhalation capsules (60-count units) with a ceiling value of $1,941.36. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures and scheduled for completion by May 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4E9GDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,879.50 to AmerisourceBergen Drug Corp for 60 capsules of INBRIJA 42 MG inhalation medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was made on January 13, 2026, with an ultimate completion date of February 4, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., which rebranded from AmerisourceBergen in recent years. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, medical devices, and related supplies across multiple therapeutic domains. AmerisourceBergen's consistent receipt of competitive awards demonstrates its capability to meet federal medical procurement requirements and supply critical pharmaceutical products to defense and military healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/12/26 |